Terms: = Skin cancer AND HER1, YOR227W AND Prognosis
3 results:
1. Non-clinical immuno-toxicological evaluation of her1 cancer vaccine in non-human primates: a 12-month study.
Barro AM; Rivero AI; Goñi AL; Navarro BO; Angarica MM; Ramírez BS; Bedoya DM; Triana CG; Rodríguez AM; Parada ÁC
Vaccine; 2012 Dec; 31(1):89-95. PubMed ID: 23142132
[TBL] [Abstract] [Full Text] [Related]
2. Objective response with lapatinib in patients with meningitis carcinomatosa derived from HER2/her1-negative breast cancer.
Onishi H; Morisaki T; Nakafusa Y; Nakashima Y; Yokohata K; Katano M
Int J Clin Oncol; 2011 Dec; 16(6):718-21. PubMed ID: 21327450
[TBL] [Abstract] [Full Text] [Related]
3. Are her1/EGFR interactions with ligand free HER2 related to the effects of her1-targeted drugs?
Kurbel S
Med Hypotheses; 2006; 67(6):1355-7. PubMed ID: 16890381
[TBL] [Abstract] [Full Text] [Related]
